The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
Frontiers in Oncology · 07.07.2023 · 13
DOI: 10.3389/fonc.2023.1218206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 07.07.2023. Verfasst von Jing Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Col…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer is a significant global health concern, and the discovery of endocrine therapy has played a crucial role in the treatment of estrogen-positive breast cancer. However, these therapies are often associated with osteoporosis-related adverse events, which increase the risk of fractures in breast cancer patients and can result in limited mobility and reduced quality of life. Previous studies have shown that osteoporosis is essential side effects of the breast cancer therapy, although the exact mechanisms remain mostly unclear. Current clinical treatments, such as bisphosphonates, cause side effects and may impact the therapeutic response to endocrine drugs. In this review, we explore the likelihood of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy and discuss the involved mechanisms as well as the therapeutic potential of drugs and drug combination strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zitieren
APA
Xu, J., Cao, B., Li, C., & Li, G. (2023). The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1218206
Vancouver
Xu J, Cao B, Li C, Li G. The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1218206
BibTeX
@article{Xu2023,
author = {Xu, Jing and Cao, Bo and Li, Chunyu and Li, Guohui},
title = {The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1218206}
}
EUVIMED